AR241159A1 - Un procedimiento para preparar un compuesto de 2-oxindol-1-carboxamida y compuesto obtenido - Google Patents

Un procedimiento para preparar un compuesto de 2-oxindol-1-carboxamida y compuesto obtenido

Info

Publication number
AR241159A1
AR241159A1 AR300259A AR30025985A AR241159A1 AR 241159 A1 AR241159 A1 AR 241159A1 AR 300259 A AR300259 A AR 300259A AR 30025985 A AR30025985 A AR 30025985A AR 241159 A1 AR241159 A1 AR 241159A1
Authority
AR
Argentina
Prior art keywords
compound
oxindol
carboxamide
preparing
procedure
Prior art date
Application number
AR300259A
Other languages
English (en)
Spanish (es)
Other versions
AR241159A2 (es
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR241159A1 publication Critical patent/AR241159A1/es
Publication of AR241159A2 publication Critical patent/AR241159A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AR300259A 1984-05-04 1985-05-02 Un procedimiento para preparar un compuesto de 2-oxindol-1-carboxamida y compuesto obtenido AR241159A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (2)

Publication Number Publication Date
AR241159A1 true AR241159A1 (es) 1991-12-30
AR241159A2 AR241159A2 (es) 1991-12-30

Family

ID=24431933

Family Applications (1)

Application Number Title Priority Date Filing Date
AR300259A AR241159A1 (es) 1984-05-04 1985-05-02 Un procedimiento para preparar un compuesto de 2-oxindol-1-carboxamida y compuesto obtenido

Country Status (25)

Country Link
JP (1) JPS60243068A (2)
KR (1) KR870000497B1 (2)
AR (1) AR241159A1 (2)
BG (2) BG60208B2 (2)
CS (1) CS252828B2 (2)
DD (1) DD232916A5 (2)
EG (1) EG17193A (2)
ES (2) ES8609248A1 (2)
FI (1) FI80016C (2)
HU (1) HU196057B (2)
IE (1) IE851103L (2)
IN (1) IN161509B (2)
MA (1) MA20424A1 (2)
MW (1) MW1685A1 (2)
MX (1) MX5839A (2)
NO (1) NO163132C (2)
OA (1) OA08098A (2)
PL (2) PL147508B1 (2)
PT (1) PT80375B (2)
RO (2) RO94455B (2)
RU (1) RU2017729C1 (2)
SU (1) SU1468413A3 (2)
YU (1) YU44998B (2)
ZA (1) ZA853324B (2)
ZW (1) ZW7885A1 (2)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis

Also Published As

Publication number Publication date
RO94455A (ro) 1988-06-30
FI851756L (fi) 1985-11-05
KR850008154A (ko) 1985-12-13
OA08098A (fr) 1987-03-31
RO91141B (ro) 1987-07-03
KR870000497B1 (ko) 1987-03-12
NO851774L (no) 1985-11-05
EG17193A (en) 1990-08-30
FI80016B (fi) 1989-12-29
RO91141A (ro) 1987-06-30
SU1468413A3 (ru) 1989-03-23
MX5839A (es) 1993-11-01
CS252828B2 (en) 1987-10-15
NO163132B (no) 1990-01-02
YU73085A (en) 1988-04-30
PL253203A1 (en) 1986-06-17
BG60207B2 (en) 1993-12-30
PL145416B1 (en) 1988-09-30
CS320285A2 (en) 1987-03-12
PL147508B1 (en) 1989-06-30
BG60208B2 (en) 1993-12-30
JPS60243068A (ja) 1985-12-03
JPH0335315B2 (2) 1991-05-27
ES551275A0 (es) 1987-07-16
RU2017729C1 (ru) 1994-08-15
ES542813A0 (es) 1986-07-16
FI80016C (fi) 1990-04-10
HU196057B (en) 1988-09-28
AR241159A2 (es) 1991-12-30
RO94455B (ro) 1988-07-01
IN161509B (2) 1987-12-19
PT80375A (en) 1985-05-01
MW1685A1 (en) 1986-09-10
PT80375B (pt) 1987-09-30
MA20424A1 (fr) 1985-12-31
HUT37754A (en) 1986-02-28
YU44998B (en) 1991-06-30
IE851103L (en) 1985-11-04
ES8609248A1 (es) 1986-07-16
ZA853324B (en) 1986-12-30
DD232916A5 (de) 1986-02-12
PL257892A1 (en) 1986-10-07
NO163132C (no) 1990-04-11
ES8707182A1 (es) 1987-07-16
FI851756A0 (fi) 1985-05-03
ZW7885A1 (en) 1985-07-24

Similar Documents

Publication Publication Date Title
ES540366A0 (es) Un procedimiento para la preparacion de un compuesto
ES547840A0 (es) Un procedimiento para la preparacion de alquilsulfonamidofe-nilalquilaminas
ES551281A0 (es) Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofeno
ES545963A0 (es) Procedimiento para la obtencion de un deposito de antibioti-co resorbible
ES557126A0 (es) Un procedimiento para la preparacion de triazolobenzodiazepinas
MX164160B (es) Un procedimiento para preparar un compuesto neoalcoxi
ES551552A0 (es) Un procedimiento para la preparacion de nuevos compuestos de sulfonilurea
ES540200A0 (es) Un procedimiento para la preparacion de acidos 7-amino-3-me-til sustituido-3-defem-4-carboxilicos
ES544863A0 (es) Un procedimiento para preparar un compuesto de beta-lactama
ES543236A0 (es) Un procedimiento para preparar un derivado de dihidropirida-zinona
ES552402A0 (es) Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas
ES553602A0 (es) Un procedimiento para la preparacion de nuevas quinazolindionas
ES557566A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indol-diona
ES542613A0 (es) Un procedimiento para la preparacion de compuesto denominado cl-1724b-2
ES546914A0 (es) Procedimiento para preparar un derivado de (imina ciclica)- difenil-eter
ES541373A0 (es) Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida
ES557156A0 (es) Un procedimiento para preparar derivados de alcanoles heteropoliciclicos
ES546574A0 (es) Procedimiento para preparar derivados de saframicina a
ES551508A0 (es) Un procedimiento para la preparacion de nuevas sulfonilureas
ES542517A0 (es) Un procedimiento para la preparacion de monoalquil-polial- quilenpoliaminas
ES544397A0 (es) Un procedimiento para la preparacion de un compuesto
ES552988A0 (es) Un procedimiento para la preparacion de piridazinilimidazolidinonas
ES551129A0 (es) Un procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-pirimidinil- o n-pirazinil-propilaminas
ES542674A0 (es) Un procedimiento para la preparacion de compuestos de cefa- losporina
ES542813A0 (es) Un procedimiento para la preparacion de un compuesto de 2- oxindol-1-carboxamida